申请人:HOFFMANN LA ROCHE
公开号:WO2005003097A1
公开(公告)日:2005-01-13
The present invention provides compounds according to formula (I ) having the designations provided herein, and pharmaceutically acceptable salts and esters thereof These compounds inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.